Abstract
A retrospective analysis (1980–1990) of normally formed low birthweight (<2500g) infants surviving to at least 28 days following intermittent positive pressure ventilation (IPPV) for longer than 12h was performed. Bronchopulmonary dysplasia (BPD) was defined as oxygen dependency at 28 days with characteristic radiographic findings. Logistic regression analysis of risk factors, before and after the initiation of IPPV was performed on 412 infants. Decreasing birth weight (BW) and gestational age (GA) were associate with an increased risk of BPD. When controlled for these variables, predictive factors prior to IPPV were gender, age at IPPV, respiratory diagnosis, and year of birth. Following IPPV, duration of peak inspiratory pressure >25cm H2O, duration of fraction of inspired oxygen (FiO2)>0.60 (DO2), maximum peak inspiratory pressure (MPIP), maximum FiO2, patent ductus arteriosus, bacteraemia and either pneumothorax or pulmonary interstitial emphysema were associated with an increased risk of BPD Adjusting for BW and GA, there was a significant reduction in BPD risk from 1980–1990 (relative odds of 0.88 for each year compared to the previous year). This trend could belargely accounted for by decreases in MPIP and DO2 during the study period. Surfactant treatment was not independently associated with a significant change in the risk of BPD. Based on this analysis, we developed a scoring system for predicting the risk of BPDL in the neonatal period which we evaluated in a random sampleof infants. This predicted infants at risk of BPD with a sensitivity of 65% and a specificity of 88%. Use of this score would allow prediction of BPD at a tim when earlier preventive treatment could be started.
Article PDF
Similar content being viewed by others
Abbreviations
- BPD:
-
bronchopulmonary dysplasia
- BW:
-
birth weight
- DO2 :
-
duration of FiO2>0.6
- DPIP:
-
duration of peak pressure >25 cm H2O
- FiO2 :
-
franction of inspired oxygen
- GA:
-
gestational age (weeks)
- IPPV:
-
intermittent positive pressure ventilation
- MO2 :
-
maximum FiO2
- MPIP:
-
maximum peak inspiratory pressure
- OR:
-
odds ratio(s)
- PaO2 :
-
arterial oxygen tension
- PaCO2 :
-
arterial carbon dioxide tension
- PDA:
-
patent ductus arteriosus
- PIE:
-
pulmonary intestitial emphysema
- PTX:
-
pneuothorax
- RDS:
-
respiratory distress syndrome
- ROC:
-
receiver operator characteristic
References
Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Ebstein MF, Fitzhardinge PM, Hansen CB, Hansen TN, Hodson WA, James LS, Kitterman JA, Nielsen HC, Poirier TA, Troug WE, Wung T-E (1987) Is chronic lung disease in low birthweight infants preventable? A survey of 8 centres. Pediatrics 79:26–30
Baker RJ, Nelder JA (1978) The GLIM system, Release 3 Generalised linear interactive modelling. Numerical Algorithms Group, Oxford
Cooke RWI (1991) Factors associated withchronic lung disease in preterm infants. Arch Dis Child 66:776–779
Collaborative European Multicenter Study Group (1988) Surfactant replacement therapyfor severe neonatal respiratory distrress syndrome: an international randomized clinical trial. Pediatrics 82:683–691
Crowley P, Chalmers I, Keirse MJNC (1990) The effect of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 97:11–25
Greenough A (1990) Bronchopulmonary dysplasia: early diagnosis, prophylaxis and treatment. Arch Dis Child 1990 65:1082–1088
Hyde I, English RE, Williams JD (1989) The changing pattern of chronic lung disease of prematurity. Arch Dis Child 64:448–451
Lupton BA, Halliday HL, Thomas PS, McClure G, Reis M McC (1987) Chronic lung diseas in a neonatal intensive care unit: 8 years experience. Ir Med J 80:254–257
McCullagh P, Nelder JA (1983) Generalized linear models. (2nd Ed) Chapman and Hall, London, pp 98–148
Metz CE (1978) Basic principles of ROC analysis Semin Nucl Med 8:283–298
Nilsson R, Grossmann G, Robertson B (1978) Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res 12:249–255
Northway WH, Rosen RC, Porter DY (1967) Pulmonary discase following respirator therapy of hyaline membrane disease. N Engl J Med 276:357–368
Palta M, Gabbert D, Fryback D, Wifjaja I, Peters ME, Farrell P, et al (1990) Development and validation of an index for scoring baseline respiratory diseas in the very low birthweight neonate. Pediatrics 86:714–721
Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirenment in the neonatal period. Pediatrics 82:527–532
Sinkin RA, Cox D, Phelps DL (1990) Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 86:728–736
Soll RF (ed) (1991) Overview of surfactant replancement trials. Oxford Database of Perinatal Trials Version 1.2; Disk Issue 6: 5206, 5252, 5664, 5675
Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O, Harms K, Herting E, McClure G, Reid M, Tumban R, Herin P, Noack G, Kok J, Koppe J, Soderen L van Laufkotter E, Kohler W, Boenisch H, Albrecht K, Hannsler L, Haim M, Oetomo SB, Okken A, Altfeld PC, Groneck P, Kachel W, Relier J-P, Walti H (1992) Randomized European multicentre trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 89:1320
Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS (1990) Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a doubleblind, controlled study. J Pediatr 117:273–282
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Corcoran, J.D., Patterson, C.C., Thomas, P.S. et al. Reduction in the risk of bronchopulmonary dysplasia from 1980–1990: Results of a multivariate logistic regression analysis. Eur J Pediatr 152, 677–681 (1993). https://doi.org/10.1007/BF01955247
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01955247